Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors

被引：0
|
作者：
Hong-tao Guo
Xue-han Bi
Ting Lei
Xiao Lv
Guang Yao
Yao Chen
Chang Liu
机构：
[1] the First Hospital of Lanzhou University,Department of obstetrics and gynecology
[2] Key Laboratory of Gynecologic Oncology Gansu Province,undefined
来源：
BMC Cancer | / 20卷
关键词：
Cervical cancer; Chemotherapy; Radiotherapy; Squamous cell carcinoma antigen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas
    Yue, Dongsheng
    Li, Hui
    Che, Juanjuan
    Zhang, Yi
    Tolani, Bhairavi
    Mo, Minli
    Zhang, Hua
    Zheng, Qingfeng
    Yang, Yue
    Cheng, Runfen
    Jin, Joy Q.
    Luh, Thomas W.
    Yang, Cathryn
    Tseng, Hsin-Hui K.
    Giroux-Leprieur, Etienne
    Woodard, Gavitt A.
    Hao, Xishan
    Wang, Changli
    Jablons, David M.
    He, Biao
    PLOS ONE, 2015, 10 (07):
  • [32] The addition of chemotherapy to adjuvant radiotherapy in patients with intermediate-risk stage IB cervical cancer and the effect on survival
    Pereira, E.
    Nair, N.
    Gorski, J.
    Schwartz, M. A.
    Zakashansky, K.
    Dottino, P.
    Kolev, V.
    Hayes, M. P.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 134 - 134
  • [33] Influence of e7 protein expression on growth factors and marker of squamous cell carcinoma (scc) in cervical cancer tissue
    Frantsiyants, E.
    Moiseenko, T.
    Pogorelova, Y.
    Nikitina, V.
    Spiridonova, D.
    Selezneva, O.
    Boyko, K.
    Vladimirova, L.
    Kravcova, O.
    Nazaralieva, N.
    Menshenina, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S538 - S538
  • [34] UTILITY OF SQUAMOUS-CELL CARCINOMA ANTIGEN (SCC AG) AS A TUMOR-MARKER IN PULMONARY MALIGNANCY
    UPHAM, J
    CAMPBELL, B
    RESPIRATORY MEDICINE, 1992, 86 (03) : 201 - 203
  • [35] Risk Stratification in Oral Cavity Squamous Cell Carcinoma by Preoperative CRP and SCC Antigen Levels
    Huang, Shiang-Fu
    Wei, Fu-Chan
    Liao, Chun-Ta
    Wang, Hung-Ming
    Lin, Chien-Yu
    Lo, Steven
    Huang, Jung-Ju
    Chen, I-How
    Kang, Chung-Jan
    Chien, Huei-Tzu
    Chen, Hsuan-Ho
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (12) : 3856 - 3864
  • [36] Risk Stratification in Oral Cavity Squamous Cell Carcinoma by Preoperative CRP and SCC Antigen Levels
    Shiang-Fu Huang
    Fu-Chan Wei
    Chun-Ta Liao
    Hung-Ming Wang
    Chien-Yu Lin
    Steven Lo
    Jung-Ju Huang
    I-How Chen
    Chung-Jan Kang
    Huei-Tzu Chien
    Hsuan-Ho Chen
    Annals of Surgical Oncology, 2012, 19 : 3856 - 3864
  • [37] Phase I study of durvalumab and tremelimumab together with radiotherapy for the adjuvant treatment of intermediate-risk head and neck squamous cell carcinoma.
    Sheth, Siddharth
    Chera, Bhishamjit S.
    Vincent, Benjamin Garrett
    Shen, Colette J.
    Weissler, Mark Christian
    Blumberg, Jeffrey
    Patel, Samip
    Zanation, Adam M.
    Yarbrough, Wendell Gray
    Patel, Shetal Arvind
    Grilley-Olson, Juneko E.
    Hackman, Trevor
    Weiss, Jared
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [38] EVALUATION OF SQUAMOUS-CELL CARCINOMA ANTIGEN (SCC-AG) IN THE DIAGNOSIS AND FOLLOW-UP OF PATIENTS WITH NON-SMALL-CELL LUNG-CARCINOMA
    NIKLINSKI, J
    FURMAN, M
    LAUDANSKI, J
    KOZLOWSKI, M
    NEOPLASMA, 1992, 39 (05) : 279 - 282
  • [39] Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix
    Juang, CM
    Wang, PH
    Yen, MS
    Lai, CR
    Ng, HT
    Yuan, CC
    GYNECOLOGIC ONCOLOGY, 2000, 76 (01) : 103 - 106
  • [40] CYFRA 21-1, SCC-Ag, CEA and selected biochemical factors of cachexia in patients with squamous cell lung cancer
    Wójcik, E
    Stasik, Z
    Reinfuss, M
    Kolodziejski, L
    Kulpa, J
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 422 - 422
12345